Current status and future directions for the diagnosis and management of mild cognitive impairment in Southeast Asia: A SEACURE consensus paper
1
Issued Date
2025-05-01
Resource Type
eISSN
24260266
Scopus ID
2-s2.0-105004391408
Pubmed ID
40082179
Journal Title
The journal of prevention of Alzheimer's disease
Volume
12
Issue
5
Rights Holder(s)
SCOPUS
Bibliographic Citation
The journal of prevention of Alzheimer's disease Vol.12 No.5 (2025) , 100110
Suggested Citation
Bhalla G., Tanoto P., Vipin A., Chen X.Y.J., Leow Y.J., Chen C., Yap P.L.K., Merchant R.A., Hilal S., Ong A.P., Ampil E.R., Idris M.I., Looi I., Dominguez J., Yusoff S., Tan M.P., Tran C.T., Tong M.T., Senanarong V., Turana Y., Kandiah N. Current status and future directions for the diagnosis and management of mild cognitive impairment in Southeast Asia: A SEACURE consensus paper. The journal of prevention of Alzheimer's disease Vol.12 No.5 (2025) , 100110. doi:10.1016/j.tjpad.2025.100110 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/110133
Title
Current status and future directions for the diagnosis and management of mild cognitive impairment in Southeast Asia: A SEACURE consensus paper
Author's Affiliation
Siriraj Hospital
Newcastle University Medicine Malaysia
Lee Kong Chian School of Medicine
Khoo Teck Puat Hospital
University of Santo Tomas Hospital
St. Luke's Medical Center Quezon City
University of Medicine and Pharmacy at HCMC
Universitas Katolik Indonesia Atma Jaya
Universitas Padjadjaran
National University Hospital
Universiti Malaya
NUS Yong Loo Lin School of Medicine
National University of Singapore
Seberang Jaya Hospital
Newcastle University Medicine Malaysia
Lee Kong Chian School of Medicine
Khoo Teck Puat Hospital
University of Santo Tomas Hospital
St. Luke's Medical Center Quezon City
University of Medicine and Pharmacy at HCMC
Universitas Katolik Indonesia Atma Jaya
Universitas Padjadjaran
National University Hospital
Universiti Malaya
NUS Yong Loo Lin School of Medicine
National University of Singapore
Seberang Jaya Hospital
Corresponding Author(s)
Other Contributor(s)
Abstract
Global aging populations are facing increased prevalence of mild cognitive impairment (MCI) - the preclinical stage of dementia characterized by single/multi-domain neurocognitive decline that does not impair an individual's normal daily functioning. Asian populations are at increased risk of developing MCI and dementia, and many cases go undetected in Southeast Asia (SEA), resulting in increased burden on patients, caregivers and national healthcare systems. There is an urgent need for efficient and scalable diagnostic and management strategies across SEA. Our findings illustrate that current strategies are limited by insufficient resources and a lack of awareness, particularly in developing SEA nations. Strategies for improving the MCI landscape in SEA include increasing widespread community awareness and cognitive health screenings for individuals with a history of vascular risk factors, validation of traditional cognitive screening tests in the respective countries, greater access to blood-biomarker testing, and the development and validation of novel digitized diagnostics.